Shell Asset Management Co. reduced its stake in shares of Stericycle Inc. (NASDAQ:SRCL) by 65.4% during the second quarter, according to its most recent filing with the SEC. The institutional investor owned 6,590 shares of the company’s stock after selling 12,461 shares during the period. Shell Asset Management Co.’s holdings in Stericycle were worth $686,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors also recently bought and sold shares of SRCL. Jana Partners LLC bought a new position in Stericycle during the first quarter valued at about $305,997,000. Swedbank purchased a new position in Stericycle during the second quarter valued at $104,155,000. Oakbrook Investments LLC purchased a new position in Stericycle during the second quarter valued at $13,871,000. BlackRock Fund Advisors boosted its position in Stericycle by 6.4% in the first quarter. BlackRock Fund Advisors now owns 1,707,528 shares of the company’s stock valued at $215,473,000 after buying an additional 103,024 shares during the last quarter. Finally, Alecta Pensionsforsakring Omsesidigt boosted its position in Stericycle by 16.7% in the second quarter. Alecta Pensionsforsakring Omsesidigt now owns 700,000 shares of the company’s stock valued at $72,877,000 after buying an additional 100,000 shares during the last quarter. 92.80% of the stock is currently owned by institutional investors.
Stericycle Inc. (NASDAQ:SRCL) traded down 1.70% on Friday, reaching $75.10. 1,574,872 shares of the company’s stock were exchanged. Stericycle Inc. has a 12 month low of $74.95 and a 12 month high of $151.57. The firm’s 50-day moving average is $81.55 and its 200-day moving average is $99.23. The firm has a market cap of $6.39 billion, a PE ratio of 26.43 and a beta of 0.20.
Stericycle (NASDAQ:SRCL) last posted its earnings results on Thursday, July 28th. The company reported $1.18 earnings per share for the quarter, hitting the Thomson Reuters’ consensus estimate of $1.18. The company had revenue of $891.60 million for the quarter, compared to analyst estimates of $910.29 million. Stericycle had a net margin of 7.22% and a return on equity of 14.84%. The business’s revenue for the quarter was up 24.6% compared to the same quarter last year. During the same period last year, the business posted $1.14 earnings per share. On average, equities analysts forecast that Stericycle Inc. will post $4.67 earnings per share for the current year.
Several equities analysts have weighed in on the stock. Zacks Investment Research cut shares of Stericycle from a “buy” rating to a “hold” rating in a research report on Thursday, July 14th. Wedbush lowered their price objective on shares of Stericycle from $95.00 to $85.00 and set a “neutral” rating on the stock in a research report on Thursday, September 22nd. Robert W. Baird lowered their price objective on shares of Stericycle from $99.00 to $85.00 and set a “neutral” rating on the stock in a research report on Friday, September 23rd. Northcoast Research cut shares of Stericycle from a “buy” rating to a “neutral” rating in a research report on Tuesday, September 20th. Finally, Jefferies Group reiterated a “buy” rating and set a $125.00 price objective (down from $140.00) on shares of Stericycle in a research report on Friday, July 29th. Four research analysts have rated the stock with a sell rating, ten have issued a hold rating and four have issued a buy rating to the company’s stock. The company has a consensus rating of “Hold” and a consensus target price of $103.54.
In other news, Director Rodney F. Dammeyer sold 10,188 shares of the stock in a transaction on Wednesday, August 17th. The shares were sold at an average price of $85.50, for a total transaction of $871,074.00. Following the completion of the sale, the director now owns 10,188 shares of the company’s stock, valued at $871,074. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP John P. Schetz sold 1,398 shares of the stock in a transaction on Wednesday, September 14th. The stock was sold at an average price of $81.85, for a total transaction of $114,426.30. Following the sale, the executive vice president now directly owns 1,088 shares of the company’s stock, valued at approximately $89,052.80. The disclosure for this sale can be found here. Insiders own 3.30% of the company’s stock.
Stericycle Company Profile
Stericycle, Inc is a business-to-business services provider with a focus on regulated and compliance solutions for healthcare, retail and commercial businesses. The Company’s solutions include the collection and processing of specialized waste for disposal, the collection of personal and confidential information for secure destruction, and a range of training, consulting, recall/return, communication and compliance services.
Want to see what other hedge funds are holding SRCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stericycle Inc. (NASDAQ:SRCL).
Receive News & Ratings for Stericycle Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle Inc. and related companies with MarketBeat.com's FREE daily email newsletter.